RGEN News and Press, Repligen Corporation From 07/27/21

Repligen (RGEN): Q2 Non-GAAP EPS of $0.79 beats by $0.27; GAAP EPS of $0.64 beats by $0.23.Revenue of $162.96M (+86.3% Y/Y) beats by $18.72M.Adjusted EBITDA of $59.67M vs. consensus of $43.4M.Shares +1.9% PM.Press Release For further details see: Repligen EPS beats by $0.27, beats on re...

Reported revenue was $163.0 million for the quarter, representing year-over-year growth of 86% and organic growth of 69% Revenue guidance raised to $625-$645 million for full year 2021 Acquisition of hollow fiber innovator Polymem S.A. completed July 1, 2021 ...

Buying and holding can be hard when stocks are swinging wildly from day to day. But research shows that trying to time the market is the most predictable way to underperform. Real wealth is built by buying companies and allowing them to compound earnings over time. It's a lot easier whe...

WALTHAM, Mass., July 13, 2021 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN) today announced that the Company will report its second quarter 2021 financial results on Tuesday, July 27, 2021. The Company will issue a press release before the market opens and will host a conference ca...

Repligen Corporation (RGEN) agreed to acquire France-based Polymem, an industrial expert in developing and manufacturing hollow fiber membranes and modules.The products of Polymen are used in water treatment, solid/liquid separation, gas separation, liquid/gas transfer, and bioprocessing appl...

WALTHAM, Mass., June 22, 2021 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it has entered into an agreement to acquire Toulouse, France based Polymem S.A. (“Polymem”), a lea...

Harding Loevner is an investment manager that invests primarily in publicly traded global equities. We were founded in 1989 by former managers for the Rockefeller family. Harding Loevner is a Delaware limited partnership. We operate independently of Affiliated Managers Group. The Glob...

WALTHAM, Mass., May 25, 2021 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will present virtually at two upcoming investor conferences. William Blair 41 st Annual Growth Stock...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips I’m excited to announce that I will be hosting a brand-new event next Wednesday, May 19, called the Accelerated Wealth Summit ! Source: Shutterstock Many people in our office are already declaring this the...

Repligen Corporation. (RGEN) Q1 2021 Results Earnings Conference Call May 04, 2021, 08:30 AM ET Company Participants Sondra Newman - Global Head of IR Tony Hunt - President and CEO Jon K. Snodgres - CFO Conference Call Participants Julia Qin - JPMorgan Dan Arias - Stifel Puneet Souda - SVB Le...